These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 24003489)

  • 1. [Clinic pharmacokinetics of a new original antipsychotic drug Dilept].
    Shevchenko RV; Litvin AA; Kolyvanov GB; Boĭko SS; Zherdev VP; Serebrova SIu; Ivashkina NIu; Neznamov GG; Siuniakov SA
    Eksp Klin Farmakol; 2013; 76(6):34-7. PubMed ID: 24003489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental pharmacokinetics of the new neurotensine-derived antipsychotic drug dilept].
    Zherdev VP; Boĭko SS; Mesonzhnik NV; Appolonova SA; Rodchenkov GN; Ostrovskaia RU; Gudasheva TA; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(3):16-21. PubMed ID: 19642587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific features in pharmacokinetics of the original neuroleptic dilept in animals and humans].
    Shevchenko RV; Litvin AA; Kolyvanov GB; Boĭko SS; Zherdev VP
    Eksp Klin Farmakol; 2014; 77(7):23-6. PubMed ID: 25322650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pharmacokinetics and relative bioavailability of tablets and substance of new dipeptide neuroleptic dilept.
    Shevchenko RV; Litvin AA; Kolyvanov GB; Zherdev VP; Smirnov VV
    Bull Exp Biol Med; 2014 Oct; 157(6):735-7. PubMed ID: 25348562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dilept: a tripeptoid neurotensin analog combining neuroleptic activity with positive mnemotropic action].
    Ostrovskaia RU; Retiunskaia MV; Guzevatykh LS; Gudasheva TA; Voronina TA; Seredin SB
    Eksp Klin Farmakol; 2005; 68(1):3-6. PubMed ID: 15786954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of the blood-brain barrier for dilept and its active metabolite.
    Zherdev VP; Boyko SS; Mesonzhnik NV; Bastrygin DV
    Bull Exp Biol Med; 2011 Jul; 151(3):330-2. PubMed ID: 22451879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The new tripeptoid neurotensin analog dilept selectively affects dopamine turnover in nucleus accumbens and hypothalamus].
    Retiunskaia MV; Kudrin VS; Klodt PM; Us KS; Gudasheva TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2005; 68(6):15-8. PubMed ID: 16405028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of dipeptide neurotensin analog dilept on extracellular concentrations of glutamate, GABA and HVA in N. accumbens of rat brain].
    Shubenina EV; Kudrin VS; Klodt PM; Narkevich VB; Gudasheva TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2010 Dec; 73(12):9-12. PubMed ID: 21395009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Decrease in the glutamate release may contribute to the neuroprotective action of the novel neuroleptic drug dilept].
    Us KS; Klodt PM; Kudrin VS; Arkhipenko NV; Gudasheva TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2007; 70(3):3-5. PubMed ID: 17650623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurotensine dipeptide analog dilept decreases the deficiency of prestimulus startle reflex inhibition: a prognostic sign of antipsychotic activity].
    Ostrovskaia RU; Krupina NA; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(5):3-7. PubMed ID: 19928566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The search of small molecules with antipsychotic activity on the background of neurotensin].
    Ostrovskaia RU; Gudasheva TA; Krupina NA; Seredin SB
    Bioorg Khim; 2012; 38(1):119-26. PubMed ID: 22792715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromodulatory mechanism underlying the effect of the atypical dipeptide neuroleptic dilept.
    Retyunskaya MV; Guzevatykh LS; Bondarenko NA; Gudasheva TA; Ostrovskaya RU; Voronina TA
    Bull Exp Biol Med; 2003 Nov; 136(5):467-70. PubMed ID: 14968162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interstrain differences in the content of excitatory and inhibitory amino acids in the brain of DBA/2J, Balb/c and C57BL/6 mice: characteristics of the effect of a dipeptide antipsychotic drug dilept].
    Shubenina EB; Kudrin VS; Klodt PM; Pokrovskiĭ AA; Gudasheva TA; Voronina TA; Ostrovskaia RU
    Eksp Klin Farmakol; 2008; 71(4):7-10. PubMed ID: 18819433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of procognitive effect of the potential antipsychotic, Dilept and its main metabolite, GZR-125 at the novel objects recognition test in rats].
    Gorelov PI; Ostrovskaia RU; Sazonova NM
    Eksp Klin Farmakol; 2013; 76(7):3-5. PubMed ID: 24006607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neurotensin dipeptide analog dilept on dopamine metabolism and synthesis in the nucleus accumbens of Wistar rats.
    Shubenina EV; Kudrin VS; Klodt PM; Narkevich VB; Kuznetsova EA; Gudasheva TA; Ostrovskaya RU
    Bull Exp Biol Med; 2012 Sep; 153(5):694-6. PubMed ID: 23113260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative fasting bioavailability of dispersible and conventional tablets of risperidone: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy male Chinese volunteers.
    Huang M; Shen-Tu J; Hu X; Chen J; Liu J; Wu L
    Clin Ther; 2012 Jun; 34(6):1432-9. PubMed ID: 22595151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers.
    Lim KS; Kwon JS; Jang IJ; Jeong JM; Lee JS; Kim HW; Kang WJ; Kim JR; Cho JY; Kim E; Yoo SY; Shin SG; Yu KS
    Clin Pharmacol Ther; 2007 Feb; 81(2):252-8. PubMed ID: 17259948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.